Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens
- 1 October 1986
- journal article
- review article
- Published by Taylor & Francis in Journal of Psychoactive Drugs
- Vol. 18 (4), 305-313
- https://doi.org/10.1080/02791072.1986.10472362
Abstract
(1986). Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens. Journal of Psychoactive Drugs: Vol. 18, MDMA: Proceedings of the Conference, pp. 305-313.Keywords
This publication has 14 references indexed in Scilit:
- Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic classJournal of Medicinal Chemistry, 1986
- Further investigation of the discriminative stimulus properties of MDAPharmacology Biochemistry and Behavior, 1984
- MDA: An agent that produces stimulus effects similar to those of 3,4-DMA, LSD and cocaineEuropean Journal of Pharmacology, 1984
- MDA: A psychoactive agent with dual stimulus effectsLife Sciences, 1983
- Antagonism of the effects of the hallucinogen dom and the purported 5-HT agonist quipazine by 5-HT2 antagonistsEuropean Journal of Pharmacology, 1983
- Effects of certain hallucinogenic amphetamine analogs on the release of [3H]-serotonin from rat brain synaptosomesJournal of Medicinal Chemistry, 1982
- A pharmacologic comparison of 3,4-methylenedioxyamphetamine and LSD in the chronic spinal dogEuropean Journal of Pharmacology, 1977
- Phenylalkylamines with potential psychotherapeutic utility. 1. 2-Amino-1-(2,5-dimethoxy-4-methylphenyl)butaneJournal of Medicinal Chemistry, 1976
- Stereospecific requirements for hallucinogenesisJournal of Pharmacy and Pharmacology, 1973
- Psychotomimetic agents related to mescalineCellular and Molecular Life Sciences, 1963